You are here

Cancer/Tumor

MIRAGAA

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

Cancer evolves through microevolution where random lesions that provide the biggest advantage to cancer stand out in their frequent occurrence in multiple samples. At the same time, a gene function can be changed by aberration of the corresponding gene or modification of microRNA (miRNA) expression, which attenuates the gene. In a large number of cancer samples, these two mechanisms might be distributed in a coordinated and almost mutually exclusive manner.

Rating: 
Average: 5 (1 vote)

activeMiRNA

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

Identifying microRNA signatures for the different types and subtypes of cancer can result in improved detection, characterization and understanding of cancer and move us towards more personalized treatment strategies. However, using microRNA's differential expression (tumour versus normal) to determine these signatures may lead to inaccurate predictions and low interpretability because of the noisy nature of miRNA expression data. We present a method for the selection of biologically active microRNAs using gene expression data and microRNA-to-gene interaction network.

Rating: 
Average: 5 (2 votes)

Exp. Verified microRNA-Target

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

Recent studies have indicated that microRNA (miRNA) may play an oncogenic or tumor suppressor role in human cancer. To study the regulatory role of miRNAs in tumorigenesis, an integrated platform has been set up to provide a user friendly interface for query. The main advantage of the present platform is that all the miRNA target genes' information and disease records are drawn from experimentally verified or high confidence records.

Rating: 
Average: 5 (1 vote)

CR2Cancer

Submitted by ChenLiang on Tue, 01/09/2018 - 17:43

Chromatin regulators (CRs) can dynamically modulate chromatin architecture to epigenetically regulate gene expression in response to intrinsic and extrinsic signalling cues. Somatic alterations or misexpression of CRs might reprogram the epigenomic landscape of chromatin, which in turn lead to a wide range of common diseases, notably cancer. Here, we present CR2Cancer, a comprehensive annotation and visualization database for CRs in human cancer constructed by high throughput data analysis and literature mining.

Rating: 
Average: 5 (1 vote)

Pages

Subscribe to Cancer/Tumor